
ImmunoPrecise Antibodies (IPA) Announces Q3 FY2025 Financial Results and Key Business Updates
ImmunoPrecise Antibodies (IPA) Achieves Strategic Milestones and Reports Q3 FY2025 Financial Results ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced its financial results for the third quarter of fiscal year 2025 (Q3 FY2025), ended…











